No Detail Found!

Computational profile of novel natural bioactive inhibitors of NF- KB

Author(s)
Muhammad Ishaq Department of Zoology, University of Education, Lahore, Pakistan
Muhammad Mansha Department of Zoology, University of Education, Lahore, Pakistan
Muhammad Faisal Maqbool Cancer Research Lab, Department of Zoology, University of the Punjab, Lahore, Pakistan
Muhammad Khan Cancer Research Lab, Department of Zoology, University of the Punjab, Lahore, Pakistan
Azeem Saeed Allama Iqbal Medical College, Lahore, Pakistan
Abstract
Nuclear factor-?B (NF-?B) represents a family of inducible transcription factors, that regulates a large array of genes involved in different processes of the immune and in ammatory responses. Deregulated NF-?B activation contributes to the pathogenic process of various diseases such as in ammation and cancer. NF-?B signaling in cancer cells is involved in cellular proliferation, angiogenesis, invasion, metastasis, development of drug resistance and antiapoptosis. Objective: To identify potent NF-?B and I?Ba inhibitors using molecular docking study. Methods: Proteins and ligands were prepared from Pymol and AutoDock vina and results were visualized by using Discovery studio visualizer. Results: Natural bioactive compounds such as Brevilin A, Tagitinin E, Japonicone G and Hiyodorilactone A were targeted on NF-?B and I?Ba. The docking score of the Brevilin A, Tagitinin E, Japonicone G and Hiyodorilactone A with NF-?B were -9.8Kcal/mol, -10.1Kcal/mol, -11.9Kcal/mol, and - 8.4Kcal/mol respectively. The docking score of the Brevilin A, Tagitinin E, Japonicone G and Hiyodorilactone A with I?Ba were 7.1Kcal/mol, -7.0Kcal/mol, -8.8Kcal/mol and -6.8Kcal/mol respectively. Control group (JSH-23 synthetic inhibitor) showed -6.5Kcal/mol and -5.5Kcal/mol with NF-?B and I?Ba respectively. Conclusions: The present study re ects that Brevilin A, Tagitinin E, Japonicone G and Hiyodorilactone A show promising results as a crucial drug target in NF-?B signaling cascade. However, to validate the inhibitory activity of these ligands further in-vitro analysis is suggested to develop novel anti-in ammatory/anti-cancer drugs.
Publication Details
Page(s) 51-58
Published Journal: Futuristic Biotechnology, Volume: 3, Issue: 3, Year: 2023

Request the full text from PASTIC

Keywords
NF KB anti cancer inflammation
0

Citations

0

Downloads

58

Views